Cargando…
Anticoagulation in COVID-19: a single-center retrospective study
Introduction: COVID-19 induces a pro-thrombotic state as evidenced by microvascular thrombi in the renal and pulmonary vasculature. Therapeutic anticoagulation in COVID-19 has been debated and data remain anecdotal. Hypothesis: We hypothesize that therapeutic anticoagulation is associated with a red...
Autores principales: | Roomi, Sohaib Sanan, Saddique, Maryum, Ullah, Waqas, Haq, Shujaul, Ashfaq, Ammar, Madara, John, Boigon, Margot |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850331/ https://www.ncbi.nlm.nih.gov/pubmed/33552407 http://dx.doi.org/10.1080/20009666.2020.1835297 |
Ejemplares similares
-
Efficacy of Hydroxychloroquine and Tocilizumab in Patients With COVID-19: Single-Center Retrospective Chart Review
por: Roomi, Sohaib, et al.
Publicado: (2020) -
Is therapeutic anticoagulation improving renal outcomes in COVID-19?
por: Roomi, Sohaib, et al.
Publicado: (2020) -
Predictability of CRP and D-Dimer levels for in-hospital outcomes and mortality of COVID-19
por: Ullah, Waqas, et al.
Publicado: (2020) -
Lymphocyte-to-C-Reactive Protein Ratio: A Novel Predictor of Adverse Outcomes in COVID-19
por: Ullah, Waqas, et al.
Publicado: (2020) -
Impact of Body Mass Index on COVID-19-Related In-Hospital Outcomes and Mortality
por: Ullah, Waqas, et al.
Publicado: (2021)